Arcade Therapeutics

Therapeutic Games to Address the $300B Mental Health Engagement Problem

https://wefunder.com/arcade.therapeutics

Total raised on Wefunder: 98833

Total investors: 26

Quick facts

  • Massive Market of $300B for untreated mental health conditions in the U.S., $1 Trillion Globally
  • Successful anxiety trial results: 68% reduced by a full severity level within 30 days
  • Named to 2024 + 2025 DHNY 100, as a top NYC Digital Health Company
  • Founding CEO with 3 exits; Chief Science Officer is anxiety expert and NIH-funded scientist
  • Contracts w/ primary care, 2 state universities, and several behavioral health partners
  • Selected for UK-based Innovation in Mental Health Programme
  • $3.8M National Institute of Mental Health grant for Depression clinical trial

Team profiles

Featured investor profiles

Arcade Therapeutics

Therapeutic Games to Address the $300B Mental Health Engagement Problem

Funded badge
Last Funded May 2025

$808,833

raised from 26 investors

What Investors Say

LEAD INVESTOR
Invested $75,000 this round + $200,000 previously
We face an acute mental health crisis with significant barriers like stigma, long wait times, inadequate payor support, and over-reliance on drugs, leading to rising depression, anxiety, suicides, and $300B in healthcare costs. Early digital therapeutics (DTx) failed due to high costs, usability issues, reimbursement challenges, and poor go-to-market strategies. Arcade, learning from these mistakes, has developed clinically effective therapeutic gaming with leaner costs, renewed pharma interest, new reimbursement options, and a strategic go-to-market plan. Recognized by media, supported by an NIH grant, and backed by institutional investors, Arcade's easy-to-use product delivers better patient outcomes.
What People Say